Stockscreener 앱 받기
0.8369
2.81%
-0.0242
시간 외 거래:
.84
0.0031
+0.37%
Aprea Therapeutics Inc 주식(APRE)의 최신 뉴스
CatalYm picks ex-Aprea CEO Christian Schade to chair board - Stock Titan
Aprea Abstract Accepted for ASCO on APR-1051 Phase 1 Study - MyChesCo
Aprea Therapeutics (NASDAQ: APRE) reporting group discloses 9.9% stake - Stock Titan
Two life sciences companies with Doylestown connections raise $119M - MSN
APRE Forecast, Price Target & Analyst Ratings | APREA THERAPEUTICS INC (NASDAQ:APRE) - ChartMill
Aprea (APRE): Buy, Sell, or Hold? | Q4 2025: EPS Beats ForecastsEV/EBITDA - Xã Vĩnh Công
Aprea Therapeutics (NASDAQ: APRE) registers 74.35M shares for resale by investors - Stock Titan
Aprea Therapeutics abstract accepted at ASCO meeting in May - Investing.com
Aprea Therapeutics abstract accepted at ASCO meeting in May By Investing.com - Investing.com Canada
Aprea Therapeutics Announces Acceptance of Abstract for Phase 1 Study of WEE1 Inhibitor APR-1051 at ASCO 2026 - Quiver Quantitative
Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting - Weekly Voice
Early human data on Aprea cancer drug lands ASCO 2026 poster slot - Stock Titan
Aprea Therapeutics (NASDAQ: APRE) seeks board authority for 1‑for‑3–1‑for‑8 reverse split - Stock Titan
Aprea reports partial response in APR-1051 cancer trial - MSN
Aprea (APRE) Stock: Why It Matters Now (Eye on Rally) 2026-04-18Hedge Fund Inspired Picks - Cổng thông tin điện tử tỉnh Lào Cai
Aprea reports 2025 results, early data for APR-1051 trial - MSN
Zentalis Surges 20% on WEE1 Inhibitor Dose Selection—But Is Aprea the Real Winner in This Space? - Barchart.com
10 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
APRE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
3 Reasons to Avoid PTLO and 1 Stock to Buy Instead - Barchart.com
Analyst Calls: Is Aprea Therapeutics Inc stock a buy or sell2026 Breakouts & Daily Profit Focused Stock Screening - baoquankhu1.vn
Merger Talk: Is Aprea Therapeutics Inc affected by consumer sentimentWeekly Risk Summary & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
3 Reasons HUBG is Risky and 1 Stock to Buy Instead - Barchart.com
Aprea Therapeutics Showcases Emerging Clinical Data for WEE1 Inhibitor APR-1051 - Barchart
Aug Macro: How does Aprea Therapeutics Inc perform in inflationary periodsCPI Data & Precise Buy Zone Tips - baoquankhu1.vn
What is the biggest uncertainty for Aprea (APRE) Stock | Price at $0.86, Up 17.17%Blue Chip Stocks - Xã Châu Thành
APRE Breaks Key Resistance—But Bears Still Lurk Below - Bitget
Janus and Tecnoglass Shares Are Soaring, What You Need To Know - Barchart.com
Why Trex (TREX) Stock Is Up Today - Barchart.com
Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings? - Barchart.com
Simply Good Foods (SMPL) Reports Q1: Everything You Need To Know Ahead Of Earnings - Barchart.com
Aprea Therapeutics, Inc.Common Stock (NQ: APRE - FinancialContent
Squadron reports 1.27M warrant stake in Aprea Therapeutics (NASDAQ: APRE) - Stock Titan
Aprea Reports Partial Response in APR-1051 Cancer Trial - MyChesCo
Why Apple (AAPL) Shares Are Falling Today - Barchart
Former Aprea CEO Christian Schade joins Frazier after Halda sale - Stock Titan
Here's What to Expect From 3M Company's Next Earnings Report - Barchart
APRE PE Ratio & Valuation, Is APRE Overvalued - Intellectia AI
APRE Stock Analysis: Aprea Therapeutics Inc. Common Stock Up 1.65 Pct at 0.72 USD - Cổng thông tin điện tử tỉnh Lào Cai
Stocks in play: CGI Inc. - Barchart.com
APRE SEC FilingsAprea Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Soleus entities and Guy Levy report 1.27M shares in Aprea (NASDAQ: APRE) - Stock Titan
Aprea Therapeutics (APRE) CFO buys pre-funded and common warrants - Stock Titan
Aprea Therapeutics (APRE) director buys pre-funded and common stock warrants - Stock Titan
Aprea Therapeutics Announces Closing of Oversubscribed $30 Million Private Placement - bitget.com
Aprea Therapeutics Raises $30M to Advance Oncology Pipeline - TipRanks
Weekly Earnings: Is Aprea Therapeutics Inc stock a buy or sell2026 Big Picture & Fast Gain Stock Tips - baoquankhu1.vn
Aprea Therapeutics closes $30 million private placement - Investing.com
0.29%
0.00%
자본화:
|
볼륨(24시간):